Wang, Lihua

Mayo Clinic · National Cancer Institute · Center for Cancer Research

1 paper on CoChatORCID 0000-0003-2741-7765

Most cited papers

Verified
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas
Kummar, S., Chen, A., Ji, J., Zhang, Y., Reid, J. M., Ames, M., Jia, L., Weil, M., Speranza, G., Murgo, A. J., et al. (2011) · Cancer Research
PARP inhibition in cancer therapyCancer therapeutics and mechanisms
Cited by 259

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free